Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study

Martina Galasso, Ludovica Verde, Renato Patrone, Giovanni Ragozzino, Giuseppe Annunziata, Annamaria Colao, Luigi Barrea, Giovanna Muscogiuri

Open source

DOI
10.3389/fendo.2026.1855886
Published
2026-07-06
Container
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1855886,
  title = {Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study},
  author = {Martina Galasso and Ludovica Verde and Renato Patrone and Giovanni Ragozzino and Giuseppe Annunziata and Annamaria Colao and Luigi Barrea and Giovanna Muscogiuri},
  year = {2026},
  journal = {Frontiers in Endocrinology},
  doi = {10.3389/fendo.2026.1855886},
  url = {https://doi.org/10.3389/fendo.2026.1855886}
}

RIS

TY  - JOUR
TI  - Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study
AU  - Martina Galasso
AU  - Ludovica Verde
AU  - Renato Patrone
AU  - Giovanni Ragozzino
AU  - Giuseppe Annunziata
AU  - Annamaria Colao
AU  - Luigi Barrea
AU  - Giovanna Muscogiuri
PY  - 2026
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1855886
UR  - https://doi.org/10.3389/fendo.2026.1855886
ER  - 

APA

Galasso, M., Verde, L., Patrone, R., Ragozzino, G., Annunziata, G., Colao, A., Barrea, L., & Muscogiuri, G. (2026). Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1855886

Source records